Prerna Mewawalla, Myeloma and Transplant Physician, Associate Professor at Drexel University, shared a post on X:
“Excited to share our multicenter study just published in Clinical Lymphoma, Myeloma and Leukemia:
Title: Real-World Outcomes of Sequential BCMA-directed therapies inRelapsed Refractory Multiple Myeloma After Belantamab Exposure
Authors: Prerna Mewawalla, Rachel Dileo, Yue Yin, Christopher Strouse, Hira Shaikh, James A Davis, Omar Alkharabsheh, Aliya Rashid, Nausheen Ahmed, Al-Ola Abdallah, Hamza Hashmi
You can read the Full Article on Clinical Lymphoma, Myeloma and Leukemia
Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared this post, adding:
“Congrats Prerna Mewawalla and all group on current publication ‘Real-world outcomes of sequential BCMA therapies in RRMM after belantamab”
More posts featuring Prerna Mewawalla